Regeneron Pharmaceuticals P/S Ratio 2010-2024 | REGN

Regeneron Pharmaceuticals current p/s ratio as of November 21, 2024 is 6.18.

  • Regeneron Pharmaceuticals average p/s ratio for 2023 was 7.19, a 31.68% decline from 2022.
  • Regeneron Pharmaceuticals average p/s ratio for 2022 was 5.46, a 7.27% increase from 2021.
  • Regeneron Pharmaceuticals average p/s ratio for 2021 was 5.09, a 37.24% increase from 2020.

P/s ratio can be defined as the price to sales or PS ratio is calculated by taking the latest closing price and dividing it by the most recent sales per share number. The PS ratio is an additional way to assess whether a stock is over or under valued and is used primarily in cases where earnings are negative and the PE ratio cannot be utilized.

Regeneron Pharmaceuticals P/S Ratio 2010-2024 | REGN

  • Regeneron Pharmaceuticals average p/s ratio for 2023 was 7.19, a 31.68% decline from 2022.
  • Regeneron Pharmaceuticals average p/s ratio for 2022 was 5.46, a 7.27% increase from 2021.
  • Regeneron Pharmaceuticals average p/s ratio for 2021 was 5.09, a 37.24% increase from 2020.

P/s ratio can be defined as the price to sales or PS ratio is calculated by taking the latest closing price and dividing it by the most recent sales per share number. The PS ratio is an additional way to assess whether a stock is over or under valued and is used primarily in cases where earnings are negative and the PE ratio cannot be utilized.